McGraw Hill Now Trading on the New York Stock Exchange
Platinum’s Jacob Kotzubei: ‘We are confident they will be a great public company.’
Company overview
- Headquartered in Mumbai, Inventia is a supplier in both semi-finished and finished Oral Solid Dosage (OSD) formulations for both regular and value-added generics.
- Inventia partners with global and leading local pharmaceuticals companies that sell in more than 40 countries across North America, South America, Europe, Southeast Asia, Middle East and Africa.
- Inventia operates both a manufacturing facility in Ambernath and a research and development facility in Thane in Maharashtra, India. The company's manufacturing platform is accredited by the U.S. FDA, U.K. MHRA and other Stringent Regulatory Authorities ("SRA").
Post 
In 
Email 
Copy link